Wednesday, October 29, 2008

The Color Purple, Fear the Purple Pill

Ask your doctor about the purple pill.

It appears that we are a nation of dutiful people who take suggestive comments made by TV and online commercials because a study revealed that AstraZeneca’s website – –aka Nexium for heartburn, generated the most traffic. It's actually brilliant marketing because everyone can remember purple pill rather than a odd sounding pharmaceutical name.

It could also be that we’re a nation of heartburn sufferers. The website generated more than one million unique visitors during the second quarter of 2008.

We’re also a nation of diabetics because Actos ranked second with 855,000 unique visitors and insomniacs ranked third with Ambien CR.

AstraZeneca aggressively marketed Nexium running approximately twice as much online display advertising in the second quarter as either of its major competitors, Prevacid and Aciphex.

Also, Pfizer ramped up marketing and public relations efforts for Lyrica since the third quarter of 2007, when the product received FDA approval to be marketed for the treatment of fibromyalgia. had a 36-percent increase in unique visitors.

Have you suffered serious side effects or life threatening injury caused by the purple pill and other heartburn related pharmaceutical drugs?

Monday, October 20, 2008

Osteoporosis - Hip Fractures Can Be Fatal

It's hell getting old.

The drug companies bombard us with a million ways how our bodies and minds will fail us and how we need to take more drugs to be saved.

If that is the case, I don't think I want saving.

Yet, I don't want a hip fracture either. My dear maternal grandmother died from a hip fracture. She really died from hospital error but it was the hip fracture that landed her in the hospital.

So what should the millions of us in the aging population be doing to reduce the risks of hip fractures?

Most people want to take a magic pill instead of eating right, exercising, practicing good habits, taking calcium, etc. Try a dose of common sense instead.

Have you taken pills like Nexium, Prevacid or Prilosec and suffered from hip fractures? If so, you may be eligible for a lawsuit. You are not alone. Pharmaceutical drugs are not always the solution; sometimes they're the problem.

Sunday, October 12, 2008

Yearly Osteoporosis Drug Approved for Men

Europe—The once-yearly Aclasta® an osteoporosis drug for men who are at risk of fractures was recently approved. Men have previously been under the radar for osteoporosis concerns but one in five men over 50 years old have suffered some kind of osteo fracture.

Data from more than 2,100 patients, showed that once-yearly Aclasta reduced the risk of new clinical fractures by 35% in men and postmenopausal women who have recently had a low-trauma hip fracture from a fall from standing height or less. Hip fractures can be a potentially life-threatening consequence of osteoporosis.

A 2-year head-to-head trial compared Aclasta with weekly oral alendronate provided additional data on the treatment of male osteoporosis.

Aclasta, which is administered by once-yearly infusion, was approved in the Europe Commission in October 2007 for the treatment of osteoporosis in postmenopausal women.

Aclasta/Reclast is the only treatment for postmenopausal osteoporosis approved in the EU and US to reduce the risk of fractures including the hip, spine and non-spine. Aclasta is also approved in more than 80 countries for the treatment of Paget's disease of the bone, the second most common metabolic bone disorder.

The most common adverse events associated with Aclasta were transient post-dose symptoms such as fever and muscle pain. Most of these symptoms occurred within the first three days following Aclasta administration and resolved within three days.

Blogger's Note: The drug is in its infant stages. It's too early to know longterm side effects. Patient beware.

If you have had serious life-threatening side effects from taking any osteoporosis related drugs, please contact an unsafe drug law firm with experience pursuing these kinds of cases.